LIPIDOSE
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Jan 2023)
What this means for you
This application is over — abandoned 09 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88460314
- Mark type
- Stylized text
- Filed
- 05 Jun 2019
- Published for opposition
- 08 Oct 2019
- Abandoned
- 09 Jan 2023
- Attorney of record
- Hae Park-Suk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical in the form of an intravenous emulsion for use as a phospholipid delivery agent for the treatment of endotoxemia and sepsis
Owner
- Sepsicure, L.L.C., New York, NY, US
- Sepsicure, L.L.C., New York, NY, US
Prosecution history
- 09 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 25 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2022 — SOU EXTENSION 5 GRANTED
- 19 May 2022 — SOU EXTENSION 5 FILED
- 24 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 May 2022 — SOU TEAS EXTENSION RECEIVED
- 20 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2021 — SOU EXTENSION 4 GRANTED
- 18 Nov 2021 — SOU EXTENSION 4 FILED
- 18 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2021 — SOU EXTENSION 3 GRANTED
- 01 Jun 2021 — SOU EXTENSION 3 FILED
- 01 Jun 2021 — SOU TEAS EXTENSION RECEIVED